Nanovesicular Drug Delivery Systems for Overcoming Antibiotic Resistance

Area of Science:

• Microbiology
• Pharmacology
• Nanotechnology

Background:

• Antibiotic resistance poses a significant global health challenge, complicating treatment and increasing healthcare costs.
• Bacteria develop resistance through mechanisms like gene mutations, altered permeability, and efflux pumps.
• Existing treatments for resistant infections are often challenging and lead to prolonged illness and hospitalization.

Purpose of the Study:

• To review strategies for overcoming antibiotic resistance.
• To highlight the potential of nano-sized drug delivery systems in combating resistant microorganisms.
• To compile data on liposomes and niosomes as nanovesicular systems for antibiotic delivery.

Main Methods:

• Literature review of current research on antibiotic resistance.
• Analysis of various strategies to overcome antibiotic resistance.
• Focus on nanoparticle drug delivery systems, specifically liposomes and niosomes.

Main Results:

• Nanoparticle drug delivery systems offer enhanced antibiotic stability, improved cell membrane permeation, and better biodistribution.
• Liposomes and niosomes show promise as nanovesicular systems for targeted antibiotic delivery.
• These systems can potentially deliver antibiotics intracellularly to combat resistant bacteria.

Conclusions:

• Nanovesicular drug delivery systems, including liposomes and niosomes, represent a promising approach to overcome antibiotic resistance.
• Targeted delivery of antibiotics via nanotechnology can enhance treatment efficacy against resistant bacterial strains.
• Further investigation into liposomes and niosomes is warranted for developing novel strategies against multidrug-resistant organisms.